Clinical significance of Vascular Endothelial Growth Factor-A expression in Ewing’s sarcoma
- 31 August 2006
- journal article
- Published by Elsevier BV in European Journal of Cancer
- Vol. 42 (12), 1904-1911
- https://doi.org/10.1016/j.ejca.2006.01.063
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- A Small Interfering RNA Targeting Vascular Endothelial Growth Factor Inhibits Ewing's Sarcoma Growth in a Xenograft Mouse ModelClinical Cancer Research, 2005
- Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and AngiogenesisJournal of Clinical Oncology, 2005
- Prognostic Relevance of Increased Angiogenesis in OsteosarcomaClinical Cancer Research, 2004
- Overexpression of vascular endothelial growth factor (VEGF) and its cellular receptor KDR (VEGFR-2) in the bone marrow of patients with acute myeloid leukemiaLeukemia, 2002
- Vascular Endothelial Growth Factor and Soft Tissue Sarcomas: Tumor Expression Correlates With GradeAnnals of Surgical Oncology, 2001
- Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluationEuropean Journal of Cancer, 1996
- Inhibition of Angiogenesis by Anthracyclines and Titanocene DichlorideAnnals of the New York Academy of Sciences, 1994
- Vinca alkaloids: Anti-vascular effects in a murine tumourEuropean Journal of Cancer, 1993
- Induction of angiogenesis during the transition from hyperplasia to neoplasiaNature, 1989
- A System for the Surgical Staging of Musculoskeletal SarcomaPublished by Ovid Technologies (Wolters Kluwer Health) ,1980